Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1126439

Development of the polymer micelle carrier system for doxorubicin

Author
NAKANISHI, T1 ; FUKUSHIMA, S1 ; OKAMOTO, K1 ; SUZUKI, M1 ; MATSUMURA, Y2 ; YOKOYAMA, M3 ; OKANO, T3 ; SAKURAI, Y3 ; KATAOKA, K4
[1] Drug Research Department, Nippon Kayaku Co., Ltd., 3-31-12 Shimo, Kita-ku, Tokyo 115-8588, Japan
[2] Department of Medicine, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan
[3] Institute of Biomedical Engineering, Tokyo Women's Medical University, 8-1, Kawada-cho, Shinjyuku-ku, Tokyo 162-0054, Japan
[4] Department of Materials Science, Graduated School of Engineering, The University of Tokyo 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan
Conference title
Proceedings of the International Symposium on Tumor Targeted Delivery Systems, Bethesda, Maryland, USA, September 25-27, 2000
Conference name
International Symposium on Tumor Targeted Delivery Systems (Bethesda, Maryland 2000-09-25)
Author (monograph)
TABIBI, S. Esmail (Editor)1 ; KOPECEK, Jindrich (Editor)2 3
National Cancer Institute, Bethesda, Maryland, United States (Funder/Sponsor)
Controlled Release Society, United States (Funder/Sponsor)
[1] Pharmaceutical Resources Branch, National Cancer Institute, NIH, Bethesda, MD 20892-7446, United States
[2] Department of Pharmaceutics and Pharmaceutical Chemistry/CCCD, University of Utah, Salt Lake City, UT 84112, United States
[3] Department of Bioengineering, University of Utah, Salt Lake City, UT 84112, United States
Source

Journal of controlled release. 2001, Vol 74, Num 1-3, pp 295-302 ; ref : 12 ref

CODEN
JCREEC
ISSN
0168-3659
Scientific domain
Pharmacology drugs
Publisher
Elsevier, Amsterdam
Publication country
Netherlands
Document type
Conference Paper
Language
English
Keyword (fr)
Animal Anthracyclines Anticancéreux Aspartate polymère Chimiothérapie Composé conjugué Cytotoxicité Dimension particule Doxorubicine Encapsulation Ethylène oxyde polymère Forme pharmaceutique Micelle Polymère vecteur Propriété physicochimique Souris Structure physique Technologie pharmaceutique Traitement Tumeur maligne Vecteur médicament Voie souscutanée Mammalia Rodentia Vertebrata
Keyword (en)
Animal Anthracyclins Antineoplastic agent Aspartate polymer Chemotherapy Conjugated compound Cytotoxicity Particle size Doxorubicin Encapsulation Ethylene oxide polymer Dosage form Micelle Control release polymer Physicochemical properties Mouse Physical structure Pharmaceutical technology Treatment Malignant tumor Drug carrier Subcutaneous administration Mammalia Rodentia Vertebrata
Keyword (es)
Animal Antraciclinas Anticanceroso Aspartato polímero Quimioterapia Compuesto conjugado Citotoxicidad Dimensión partícula Doxorubicina Encapsulación Etileno óxido polímero Forma farmacéutica Micela Polímero vector Propiedad fisicoquímica Ratón Estructura física Tecnología farmacéutica Tratamiento Tumor maligno Vector medicamento Vía subcutánea Mammalia Rodentia Vertebrata
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02A General pharmacology / 002B02A03 Pharmaceutical technology. Pharmaceutical industry

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents / 002B02R02 Chemotherapy

Discipline
General pharmacology Pharmacological treatments
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
1126439

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web